Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Methylphenidate Response in ADHD
NCT00773916Phase 4Completed
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- Mar 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Universidade Federal do Rio Grande do Sul. Primary endpoints: Swanson, Nolan, and Pelham-IV Questionnaire at 6 months and Clinical Global Impression at 6 months. Started Mar 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00773916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773916.